- Home
- CLH vs HOLX Comparison
CLH vs HOLX Comparison
Compare CLH & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLH | HOLX |
|---|---|---|
| Founded | 1980 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 16.6B |
| IPO Year | 1987 | 1990 |
Fundamental Metrics
Financial Performance| Metric | CLH | HOLX |
|---|---|---|
| Price | $237.03 | $74.98 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 15 |
| Target Price | ★ $252.45 | $79.64 |
| AVG Volume (30 Days) | 622.3K | ★ 3.0M |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.20 | 2.49 |
| Revenue | ★ $5,962,257,000.00 | $4,100,500,000.00 |
| Revenue This Year | $2.95 | $6.69 |
| Revenue Next Year | $4.16 | $5.74 |
| P/E Ratio | $32.97 | ★ $30.11 |
| Revenue Growth | ★ 2.85 | 1.74 |
| 52 Week Low | $178.29 | $51.90 |
| 52 Week High | $255.44 | $80.31 |
Technical Indicators
Market Signals| Indicator | CLH | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 64.98 | 67.93 |
| Support Level | $213.85 | $74.55 |
| Resistance Level | $242.18 | $75.12 |
| Average True Range (ATR) | 6.56 | 0.28 |
| MACD | 3.53 | -0.14 |
| Stochastic Oscillator | 88.43 | 78.92 |
Price Performance
Historical ComparisonAbout CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.